Not Signed In - Chemokine Therapeutics Announces Results From CTCE-0214 Clinical Trials Program
Sat, 23 Dec 2006 08:00 AM EST
... Chemokine Therapeutics Corp. (the "Company") (TSX:CTI, OTCBB:CHKT), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders, and vascular diseases, is pleased to announce results of clinical trials of its hematological drug candidate, CTCE-0214. [click link for full article] ...
Related Topics
- Clinical Trials
- Pharmacology
- Psychopharmacology
- Health psychology
- Clinical Growth Charts
- Brain injury that results in physical, emotional, or intellectual changes or deficits
- Pediatric Aids
- Hypnotherapy
- Epidemiology
- Clinical Laboratory Improvement Amendments
- Depression
- Infectious Diseases
- Western/Clinical Treatment and Therapy
- Patient Issues
- Epidemiology & Prevention of Vaccine-Preventable Diseases
- Wellness
- Exercise for Seniors
- Wellness and Lifestyle
- Incarceration
- Sports Fitness
email this page
print this page
bookmark this page
feedback on this page
